Half of pharma leaders prioritize AI

AI reshapes drug discovery end-to-end

AI targets the right patients & leads

Is Merck's AI playbook India's next?

Lupin pilots AI across the value chain

Lupin's cardiac AI: India's leapfrog?

Are Indian GCCs calling the AI shots?

India's big data gap slows pharma AI

Garbage in, catastrophe out in pharma

Is AI's cost worth it for pharma?

How Lupin learned to fear AI obsolescence

Can India's AI framework match its ambition?

Rapid Fire

Credits

Is AI in pharma just hype or a full-blown revolution? In this episode, ET's pharma editor Vikas Dandekar sits down with three industry heavyweights Sujay Shetty, Partner & Leader - Health Industries, PwC India, Phanimitra B, Chief Digital and Information Officer, Dr. Reddy’s and Ramesh Swaminathan, ED, Global CFO, Head of IT, Lupin to unpack how artificial intelligence is transforming drug discovery, clinical trials, manufacturing, and even org design. From AlphaFold collapsing years of R&D into weeks, to Lupin deploying Gen AI across 90+ data repositories, this conversation goes deep into what's actually working, who's winning, and why the companies without an AI roadmap risk being left behind.  Listen in:

You can follow Anirban Chowdhury on his social media: X and Linkedin

Check out other interesting episodes like: How Will a Volatile ₹ Impact You in 2026?, How Quick Commerce is Triggering a Health Crisis for Gen Z, India’s Labour Law Reboot, Viral to Valuation: Building Women’s Cricket as a Brand and much more.


Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

Is AI in pharma just hype or a full-blown revolution? In this episode, ET's pharma editor Vikas Dandekar sits down with three industry heavyweights Sujay Shetty, Partner &amp; Leader - Health Industries, PwC India, Phanimitra B, Chief Digital and Information Officer, Dr. Reddy&rsquo;s and Ramesh Swaminathan, ED, Global CFO, Head of IT, Lupin to unpack how artificial intelligence is transforming drug discovery, clinical trials, manufacturing, and even org design. From AlphaFold collapsing years of R&amp;D into weeks, to Lupin deploying Gen AI across 90+ data repositories, this conversation goes deep into what's actually working, who's winning, and why the companies without an AI roadmap risk being left behind.&nbsp; Listen in: You can follow Anirban Chowdhury on his social media:<a href="https://twitter.com/AnirbanET"> X</a> and<a href="https://www.linkedin.com/in/anirban-chowdhury-b5067219/"> Linkedin</a>
Check out other interesting episodes like:<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000742733036"> How Will a Volatile ₹ Impact You in 2026?</a>,<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000740924439"> How Quick Commerce is Triggering a Health Crisis for Gen Z</a>,<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000738734300"> India&rsquo;s Labour Law Reboot</a>,<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000738205536"> Viral to Valuation: Building Women&rsquo;s Cricket as a Brand</a> and<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777"> much more</a>.
 Catch the latest episode of &lsquo;The Morning Brief&rsquo; on<a href="https://economictimes.indiatimes.com/podcast?from=mdr"> The Economic Times Online</a>,<a href="https://open.spotify.com/show/6PL5kfPbwURBEu6fHCVTOL?si=26ec0fbfa7134fea"> Spotify</a>,<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777"> Apple Podcasts</a>,<a href="https://www.jiosaavn.com/shows/the-morning-brief/1/GNPiFQD2xpY_"> JioSaavn</a>,<a href="https://music.amazon.in/podcasts/f378141f-9afb-495d-83da-9b08ec5047ac/the-morning-brief"> Amazon Music</a> and<a href="https://www.youtube.com/@theetpodcasts"> Youtube</a>.

To make sense of the week’s hottest stories in business, economy, politics and markets, journalists from the Economic Times chat with reporters and industry leaders in this thrice-weekly (Tuesday, Thursday, Friday) podcast.

The Morning Brief

Pharma's AI Reckoning